Search research articles
Contact Us
Filters
Showing results (101-110 of 173) with videos related to
Page
of 18
Sort By:
The American Journal of Clinical Nutrition
|
September 1, 2000
Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F(2)-isoprostanes
J V Higdon, J Liu, S H Du, et al.
The American Journal of Pathology
|
September 17, 1999
The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients
T J Montine, W R Markesbery, W Zackert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
January 1, 1997
Prostaglandin F2alpha is required for NMDA receptor-mediated induction of c-fos mRNA in dentate gyrus neurons
L S Lerea, N G Carlson, M Simonato, et al.
The Journal of Biological Chemistry
|
September 20, 1996
Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo
J D Morrow, J A Awad, A Wu, et al.
Archives of Pathology & Laboratory Medicine
|
March 22, 2001
Cerebrospinal fluid abeta42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls
T J Montine, J A Kaye, K S Montine, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 21, 2000
Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists
C M Reilly, J C Oates, J A Cook, et al.
The Journal of Biological Chemistry
|
July 12, 2001
Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo
K R Kozak, B C Crews, J L Ray, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1990
A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism
J D Morrow, K E Hill, R F Burk, et al.
Behavioural Brain Research
|
September 17, 2022
A mechanical task for measuring sign- and goal-tracking in humans: A proof-of-concept study
L M Cope, A Gheidi, M E Martz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 1999
Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse
S R Ritland, J A Leighton, R E Hirsch, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 173) with videos related to
Sort By:
Page
of 18
The American Journal of Clinical Nutrition
|
September 1, 2000
Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F(2)-isoprostanes
J V Higdon, J Liu, S H Du, et al.
The American Journal of Pathology
|
September 17, 1999
The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients
T J Montine, W R Markesbery, W Zackert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
January 1, 1997
Prostaglandin F2alpha is required for NMDA receptor-mediated induction of c-fos mRNA in dentate gyrus neurons
L S Lerea, N G Carlson, M Simonato, et al.
The Journal of Biological Chemistry
|
September 20, 1996
Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo
J D Morrow, J A Awad, A Wu, et al.
Archives of Pathology & Laboratory Medicine
|
March 22, 2001
Cerebrospinal fluid abeta42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls
T J Montine, J A Kaye, K S Montine, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 21, 2000
Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists
C M Reilly, J C Oates, J A Cook, et al.
The Journal of Biological Chemistry
|
July 12, 2001
Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo
K R Kozak, B C Crews, J L Ray, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1990
A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism
J D Morrow, K E Hill, R F Burk, et al.
Behavioural Brain Research
|
September 17, 2022
A mechanical task for measuring sign- and goal-tracking in humans: A proof-of-concept study
L M Cope, A Gheidi, M E Martz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 1999
Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse
S R Ritland, J A Leighton, R E Hirsch, et al.
Page
of 18